Biotech Stocks

Related articles

Race Oncology Shares Soar as They Produce a Stunning Win in Leukaemia Trial

Cancer has long been one of the great evils of healthcare. It is easily one of the most insidious and prolific group of diseases society has dealt with. A burden that we are constantly struggling to find better ways to deal with. We are making progress though.

What Is ‘COZEN-20’ and Will It Kill You Next?

There’s a new virus that apparently has just been discovered. The scary thing is that it has been circulating for some time now. Actually, it’s believed this new virus has been circulating for as long as COVID-19 or may have started just after it...

The Battle for Inner Space Begins: Biotech Wars Are Only Getting Started

The biotech wars are only getting started. There’s no doubt that whatever country can create a COVID-19 vaccine first, will enjoy a huge economic advantage over competing countries. The race for a COVID-19 cure is shaping up to be just as important as the space race was in the '60s...

The Race Is On to Find a COVID-19 Vaccine — How Close Are We?

There are 12 companies in the race to find a vaccine for COVID-19. And global stock markets are already bouncing back hard on the back of news that a solution is close. There’s no doubt it’ll be a great moment for humanity when we get this cure...

This Biotech Investment Opportunity Is More than Just Drugs

When it comes to biotech, it's easy to get hung up on drugs.Ryan Dinse has spent the last three days covering Synthetic Biology. Or as he likes to call it, ‘synbio’. This is a story that you won’t find anywhere else, and an investment opportunity that can’t be ignored...

Acrux Share Price Jumps on News of New Deal in US (ASX:ACR)

Another day, another biotech winner. The Acrux Ltd [ASX:ACR] share price is up 33.33% at time of writing. Surging on the back of confirmation of a new deal in the US. They’ve joined forces with private company TruPharma...